Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke

In this seminar, Luke Lemmerman will present his recently published work regarding the use of nanotechnology-driven non-viral vasculogenic reprogramming as a promising therapeutic strategy against ischemic stroke in a mouse model.

Questions? Please contact Julie Hannahs